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Abstract
This paper presents a case of a young patient with cyanosis and digital clubbing, until then an active, sporty person. He sought 
medical assistance due to the growing dyspnoea and the drop of effort tolerance. Initially the diagnostic process focused on the 
confirmation of the suspicion of pulmonary fibrosis or another interstitial lung disease as causes of the respiratory failure. Due 
to the atypical presentation of the symptoms, reaching the final diagnosis of digestive system disease with lung involvement 
required a more thorough multifaceted diagnostics of a number of systems and organs. 
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Introduction
Digital clubbing and cyanosis are symptoms 
of anoxaemia and changes in the circulatory sys-
tem and tissues that correspond to it. They bring 
associations with a  long-term disease process, 
which in the course of time leads to the defect of 
haemoglobin oxygenation and deviations in the 
physical examination of the patient. Rarely are 
these changes described in young people. Due 
to their uniqueness they require that numerous 
potential diseases should be taken into account. 
Besides a number of neoplastic diseases (lung 
cancer, metastatic disease with lesions in lungs, 
hematologic malignancies), they can occur in the 
course of heart diseases (cyanotic heart defects, 
arteriovenous malformations, endocarditis), dis-
eases of the respiratory system (interstitial pneu-
monitis, bronchiectasis), diseases of the digestive 
system (Crohn’s disease, ulcerative colitis, liver 
cirrhosis), diseases of the endocrine system (hy-
perthyroidism) and diseases of the connective tis-
sue [1]. Owing to the probably multidisciplinary 
etiology of the lesions, the differential diagnosis 
requires a number of laboratory tests, as well as 
imaging and endoscopic examinations in order 
to eliminate concomitant disorders. 
This study presents a case of a young patient 
with cyanosis and digital clubbing, till then an ac-
tive, sporty person. He sought medical assistance 
due to the growing dyspnoea and the drop of effort 
tolerance. Initially the diagnostic process focused 
on the confirmation of the suspicion of pulmonary 
fibrosis or another interstitial lung disease as caus-
es of the respiratory failure. Due to the atypical 
presentation of the symptoms, reaching the final 
diagnosis required a more thorough multifaceted 
diagnostics of a number of systems and organs. 
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Case study
The patient aged 28 reported in March 2009 
in the Internal Diseases Ward due to the reduction 
of the effort tolerance growing for the previous six 
months, with the concurrent dyspnoea, cough, 
and loss of the body weight. Until then the patient 
had been an active person, a lawn tennis player. As 
of the moment of reporting to the ward, walking 
a distance of several dozen metres caused dysp-
noea that required rest. The professional history 
of the patient did not mention any exposures to 
chemical substances, dusts and gases. Due to an 
injury in the area of the hip joint with the conse-
quential bone necrosis, the patient had undergone 
the hip replacement procedure in April 2006. 
At admission, confirmed deviations from the 
normal condition included central cyanosis and 
digital clubbing. What attracted attention was 
the accelerated heart rate to ca. 110 per minute, 
at normal values of the blood pressure. 
Lab tests revealed polyglobulia with the hae-
moglobin concentration of 19.2 g/dl, leukopenia 
3 × 10(3)/dl, thrombocytopenia 69 × 103/dl, in-
creased GGTP activity to 194 U/l. Serological 
tests for detection of viral infections (HBs an-
tigen, anti-HCV antibodies, 4th generation HIV 
combo test) revealed no deviations. The arterial 
blood gases analysis revealed hypoxemia (partial 
pressure of oxygen (pO2) 50 mm Hg) with the re-
duction of the blood saturation to 86% and partial 
pressure of carbon dioxide (pCO2) of 27 mm Hg. 
The diagnostics was completed with a number of 
imaging examinations of the patient’s chest and 
abdominal cavity. In the chest radiograph, besides 
an intensified vascular pattern and pleural thick-
ening in the lung apices, no other deviations were 
revealed. As a result of the computed tomography 
(CT) angiography of the pulmonary arteries, pul-
monary embolism was excluded; nevertheless, in 
the fragmentarily covered abdominal cavity struc-
tures which might correspond to thickened veins 
were demonstrated. Furthermore, fibrous lesions 
of top segments of the lower and upper lobes of 
both lungs were discovered. The abdominal ul-
trasonography (USG) and the echocardiography 
tests did not reveal any lesions. 
Due to the lesions described in the CT an-
giography, an endoscopic examination of the 
upper part of the digestive tract was performed, 
revealing slightly thickened veins of the oesoph-
agus, erosive gastritis, and insufficiency of the 
stomach cardia.
As it was impossible to determine the source 
of the patient’s condition, he was referred to the 
specialist respiratory hospital with the diagnosis 
of chronic respiratory failure for further diag-
nostics. 
The blood count tests and biochemical tests 
carried out in the specialist hospital confirmed the 
deviations revealed in the internal diseases ward. 
Due to the haematological parameters, a bone 
marrow biopsy, a proteinogram, and a screening 
test towards antinuclear antibodies (ANA) were 
performed. In the myelogram features of the acti-
vation of the red blood cells were demonstrated, 
but no features of a neoplastic infiltration were 
revealed. The result of the proteinogram remained 
within normal limits. The examination towards 
ANA did not reveal the presence of antinuclear 
antibodies. 
In the repeated USG examination of the ab-
dominal cavity the ultrasonographist described 
thickened blood vessels of the hilum of the spleen. 
The bronchofiberoscopic examination was 
performed, which revealed congestion of the mu-
cous membrane of the bronchi, with numerous 
thickened winding vessels. Material was taken 
in order to carry out cytological, bacteriological 
(also towards tuberculosis), mycological, and 
bronchoalveolar lavage (BAL) cytology tests. In 
the material no pathogenic bacteria, no Mycobac-
terium tuberculosis, no fungi and no neoplastic 
cells were revealed. The cell pattern of BAL re-
mained within the normal limits. 
The function tests of the respiratory system 
did not reveal any significant ventilation dis-
orders in spirometry; in the CO diffusion test 
(DLCO), however, the lowering of this parameter 
to 41% of the due value was confirmed. 
Measurements of the blood saturation were 
taken in the supine and standing positions and 
demonstrated orthodeoxy. 
Due to the orthodeoxy, the echocardiographic 
examination was repeated and supplemented 
with the intravenous injection of shaken saline. 
Air bubbles appeared in the left half of the heart 
after 4 cycles of the heart activity, which cor-
responds to echocardiographic features of the 
extracardiac leak (Fig. 1).
Due to the fact that chronic hypoxia with 
orthodeoxy, features of impaired diffusion in 
the lungs, the extracardiac leak along with a set 
of deviations which might be suggestive of liver 
damage had been revealed (drop in the number 
of thrombocytes and leukocytes, presence of 
oesophageal varices), a suspicion of the hepato-
pulmonary syndrome (HPS) was formulated. The 
patient was qualified to home oxygen therapy, 
the oxygen flow optimal for the normalisation 
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Figure 1. Echocardiogram. A — Contrast in the right part of the heart; 
B — contrast in both parts of the heart after 4 cycles of heart activity
A
B
of the gasometric parameters was determined; 
the patient was referred to the consulting centre 
of home oxygen therapy, where he received the 
oxygen concentrator. Consultations with the gas-
troenterology and hepatology specialist hospital 
were carried out and the date of admitting the 
patient for the purposes of further hepatologic 
diagnostics was set. 
The tests carried out in the gastroenterologi-
cal specialist hospital did not reveal any features 
of autoimmune hepatitis, hemochromatosis or 
Wilson’s disease, features of liver damage caused 
by the Epstein-Barr virus, cytomegalovirus and 
Herpes Simplex virus infection (May 2009). 
Imaging examinations of the abdominal 
cavity (USG and magnetic resonance) revealed 
thickened vessels of the spleen hilum, features 
of intensified collateral perisplenic and perirenal 
circulation, especially on the left kidney side, 
features of heterogeneous hepatic perfusion, and 
poor flow in the portal vein and in the splenal 
vein – the radiologist who described the results 
suggested indirect features of past thrombosis of 
these vessels. 
In order to confirm the diagnosis of the HPS 
the albumin scintigraphy was performed. The 
perfusion imaging revealed varying saturation of 
the right lung, distribution of the radiotracer in 
the central nervous system, kidneys, thyroid, and 
the digestive system. The calculated index of the 
right-left leak equalled 42% (value that excludes 
HPS — below 6%). The examination confirmed 
the extracardiac right-left leak suspected on the 
basis of the echocardiographic examination. 
Liver biopsy was performed, on the basis 
of which features of fibrosis of the 3rd and 4th 
degree were confirmed. 
On the basis of the clinical picture and the 
additional tests performed, liver cirrhosis of un-
known etiology was diagnosed, with respiratory 
failure in the course of the hepatopulmonary 
syndrome. 
Due to the overall clinical picture, the process 
of qualifying the patient to the hepatic transplan-
tation was commenced. In the course of qualifi-
cation the presence of anti-HBc antibodies was 
detected, indicating past viral B hepatitis as the 
probable cause of the liver cirrhosis. 
The patient was presented on an interdis-
ciplinary council, which qualified him to the 
hepatic transplantation. 
The hepatic transplantation was performed 
in the specialist hospital of general, transplant 
and liver surgery in January 2010, 15 months 
after the symptoms of the respiratory failure had 
commenced in the patient. The procedure itself 
and the postsurgical period was with no compli-
cations. In the post-transplantation period the 
respiratory failure persisted and the patient still 
required further oxygen therapy. The patient was 
discharged home with recommendations to take 
immunosuppression drugs (Prednisone in the 
dose of 15 mg, Tacrolimus 6 mg in two divided 
doses), anticoagulants (Nadroparin 3800 units 
twice a day), antimicrobial agents (Trimethoprim, 
Sulphamethoxazole, Aciclovir, Fluconazole), 
Omeprazole, Furosemide, calcium and mag-
nesium supplementation, and oxygen therapy 
continuation. Further pulmonological and trans-
plantation follow-up was planned. 
One month after the transplantation the 
patient reported to the Emergency Room com-
plaining about pain in his chest. Based on the 
ECG examination and measurements of cardiac 
markers, acute coronary syndrome was excluded 
as a potential cause of the pain. The biochemical 
tests performed revealed hyponatremia of 121 
mmol/l. The patient was admitted to gastroen-
terological specialist hospital, where the con-
centration of sodium was normalised by means 
of the fluid therapy. Furthermore, the intake of 
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Table 1. Control parameters in the respiratory system function tests 
Date/ 
/measurement 
05.2009 03.2010 06.2010 09.2010 05.2011 01.2012 29.01.2013
pO2 atmospheric 
oxygen, sitting po-
sition [mm Hg]
51.1 49.7 72.2 78,4 108 131 124
pO2 atmospheric 
oxygen, supine 
position [mm Hg]
Not  
determined 
56.2 70.7 114 115 131 119
pO2 at Fi02 1.0 
[mm Hg]
Not  
determined
250 234 440 386 Not  
determined
391
DLCO [value due] 41% 28% Not  
determined
Not  
determined
66% 63% 52.7%
6MWT [m] Not  
determined
465 600 685 750 790 705
6MWT saturation 
before ≥ after
Not  
determined
80% ≥ 57% 91% ≥ 77% 97% ≥ 86% 97% ≥ 84% 97% ≥ 87% 97% ≥ 88%
6MWT — 6 minute walk test
Fluconazole was discontinued and the dose of 
Tacrolimus was reduced under the control of the 
concentration in serum. The episode of hypo-
natremia was most probably connected with the 
increase of the concentration of Tacrolimus in 
blood due to the suppression of CYP35 enzyme 
by Fluconazole.
The patient remained under constant pul-
monological control and the supervision of the 
consulting centre of home oxygen therapy. The 
successively performed check-ups of the func-
tions of the respiratory system (Table 1) point 
out to a slow increase of the value of the partial 
pressure of oxygen, which six months after the 
transplantation (June 2010) exceeded 60 mm Hg. 
The value of diffusion increased from the lowest 
described 28% of the normal value to ca. 60%. 
The distance in the test of the 6-minute walk in-
creased considerably; nevertheless, a significant 
drop in saturation after exercise was observed at 
the value of 10%. Considering the above, contrast 
echocardiography was performed. No features 
of leak were revealed at rest, during the Valsalva 
maneuver single bubbles of the contrast agent 
were observed after 3 cycles of the heart activity. 
The patient was diagnosed as suffering from the 
intrapulmonary vascular dilatation syndrome af-
ter the hepatic transplantation for liver cirrhosis. 
Due to the improvement of the arterial blood 
gases parameters and increasing tolerance of 
effort, the patient required only periodical ap-
plication of the oxygen concentrator. The patient 
returned to his professional work. Due to the 
gasometric values, their stabilisation after the 
hepatic transplantation, the patient returned the 
oxygen concentrator (12.2015) — the cause of the 
respiratory failure had ceased. 
Discussion 
Liver cirrhosis has its influence on all organ 
systems of the human organism, including he-
modynamic parameters and the gas exchange in 
lungs. Hepatopulmonary syndrome is a pulmo-
nary complication of the liver disease connected 
with the defect of blood oxygenation in the vas-
cular bed of lungs. Although the first case was 
described in 1884, the term HPS was introduced 
only in 1977 by Kennedy. It is also combined with 
the occurrence of portal hypertension; however, 
this syndrome can be caused by every chronic 
disease of the liver, as well as some causes of 
acute liver damage [2–4]. In the subject litera-
ture HPS is estimated to be 4% to 32% of adult 
patients with the end-stage liver disease. In the 
population of children this refers to 9–20%. The 
most frequent liver pathology that leads to HPS 
is liver cirrhosis; nevertheless, the course and 
manifestation of the syndrome does not depend 
on the root cause of the liver damage. The devel-
opment of HPS has been described in the course 
of the Budd-Chiari syndrome, in portal hyperten-
sion without any chronic liver disease, as well as 
in liver diseases without concomitant cirrhosis 
and portal hypertension [5, 6]. The syndrome is 
defined as the concurrence of a  triad of symp-
tom: liver damage which may be concomitant 
with portal hypertension, hypoxemia resulting 
from the disorders in the ventilation to perfu-
sion ratio, and thickening of the intrapulmonary 
Michał Zieliński et al., Dyspnoea, cyanosis and digital clubbing as a diagnostic challenge
343www.journals.viamedica.pl
vascular bed [2, 7]. Pathophysiology of disorders 
in the pulmonary circulation has not been fully 
clarified yet; nevertheless, there is a body of 
evidence confirming the role of mediators with 
vasoactive properties, such as nitric oxide (NO), 
or the tumour necrosis factor a (TNF-a). The role 
of accumulation of macrophages stimulated by 
the increase of the concentration of endotoxins 
caused by the deterioration of the liver functions 
has been postulated, as well. Substances with the 
angiogenic potential produced by macrophages 
cause the increase of the number of capillaries 
and stimulate intervascular connections [3, 5, 7].
Depending on the author, the dissemination 
of HPS is estimated in quite broad limits. This 
results from the fact that the precise definition 
of HPS remains subject of controversies and dif-
ferent authors adopt different cut-off points for 
diagnostic criteria. In the latest guidelines from 
2016 the International Liver Transplantation 
Society recommends that the oxygenation defect 
should be defined in compliance with the criteria 
proposed by the European Respiratory Society 
(ERS) as an alveolar-arterial gradient at the level 
of at least 15 mm Hg. It is recommended to adopt 
the value of 20 mm Hg as the minimum value for 
the group of patients above 64 years of age [8, 
9]. In the patient described herein the gradient 
equalled 67 mm Hg. The intensification of HPS 
is categorised on the basis of the partial concen-
tration of oxygen in arterial blood. This division 
distinguishes 4 degrees. In the patient described 
herein the value of pO2 at the level of 49 mm Hg 
classifies him in the fourth — the highest — stage 
[3]. This value along with the diagnosis of liver 
cirrhosis obliges to commence the qualification 
process leading to the liver transplantation. 
The standard for the diagnostic screening in 
order to reveal the extracardiac blood leak is the 
transthoracic echocardiography with contrast 
obtained by means of shaken saline. In the case 
of normal vessels of the pulmonary vascular bed, 
when the contrast becomes visible in the left 
part of the heart, it is stopped in the pulmonary 
alveoli. In HPS the occurrence of contrast bubbles 
above 3 cycles of the activity of the heart after 
they become visible in the left part of the heart is 
characteristic, as it was confirmed in our patient. 
Abrams in his work dated 1995 suggests regarding 
the lack of leak features in the transthoracic echo-
cardiography as the HPS exclusion criterion [10, 
11]. An alternative test seems to be the examina-
tion of perfusion by means of technetium (99mTc) 
macroagreggated albumin and the comparison 
of its distribution in the brain and in lungs. The 
drawback of this test is the impossibility of dif-
ferentiating between the intra- and extracardiac 
leak; nevertheless, in the event of a concomitant 
lung disease with hypoxemia it constitutes a sig-
nificant indicator of the participation of the HPS 
component in the gas exchange balance disorders. 
Furthermore, a high leak factor in the perfusion 
test (defined as the value exceeding 20%, at pO2 < 
50 mm Hg) according to some authors has a posi-
tive correlation with the increase of the mortality 
rate after liver transplantation and can be used as 
a guideline referring to the steps to be undertaken 
after the transplantation [10]. The examination of 
the effectiveness of diagnostic strategies revealed 
that the most cost-effective can be additional use 
of pulse oximetry as the first screening element 
before imaging examinations [12]. In the patient 
described herein during the diagnostic process 
the blood saturation was determined, and then 
echocardiography and perfusion tests were per-
formed. The results obtained confirmed the extra-
cardiac leak with a high leak factor, indicating the 
risk of complications in the post-transplantation 
period. Oxygen supplementation is the first thera-
peutic option proposed to HPS patients. The main 
assumption for the adoption of this method is the 
control of the symptoms, because the presence of 
the leak hampers the appropriate correction of 
gasometric disorders [8, 13]. In the case described 
herein, the patient was qualified to home oxygen 
therapy on the basis of the rules applied in other 
diseases with the respiratory failure. Despite the 
described high leak factor, full compensation of 
the respiratory failure was successfully obtained 
(pO2 > 60 mm Hg) without any significant reten-
tion of carbon dioxide. Another treatment taken 
into consideration is the adoption of portosys-
temic anastomosis with the objective to reduce 
the pressure in the basin of the portal vein. The 
available subject literature covers casuistic works 
and small groups of patients with a short period 
of observations after the procedure. The results 
obtained are contradictory, as of today there are 
no clear-cut criteria that would allow to isolate 
a group of patients with HPS obtaining measur-
able benefits by the application of the vascular 
anastomosis. [14–16] As a palliative procedure, 
embolisaton of thickened vessels or local resec-
tions of the pulmonary tissue that contains them 
is adopted [7]. In connection with the values 
obtained in gasometry in the patient described 
herein, the patient was directly qualified to lung 
transplantation as the target treatment. 
Despite the fact that HPS is an indication 
for liver transplantation, it also constitutes a risk 
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factor of postoperative complications. The death 
hazard ratio in patients with HPS compared to 
patients without HPS equals 2.41 [17]. In patients 
with HPS in the period that directly follows the 
surgery rapid deterioration of gasometric parame-
ters may occur, which is probably connected with 
the blood flow redistribution. Despite the fact that 
it is a reversible phenomenon, it may contribute 
to death in the post-operative period. It corre-
lates with a low value of pO2 obtained before the 
surgery during breathing with the atmospheric 
air, which occurred in the described patient [18]. 
A separate issue is the reversibility of the 
oxygenation defect after the liver transplantation. 
In more than a half of the patients in the group 
described by French researchers in the early 
post-operative period gas exchange disorders 
persisted; they did not, however, correlate with 
the general post-operative mortality. In 15 out of 
21 patients the period of 6 subsequent months 
brought about an improvement in terms of ox-
ygenation (defined as the increase of pO2 above 
70 mm Hg). The average period over which the 
patients required the oxygen treatment reached 
3 months after the transplantation [18] in the 
patient described herein the improvement criteria 
described above were satisfied over the period of 
5 months after the liver transplantation. In spite 
of this, residual features of thickening of the 
pulmonary vessels persisted. 
From amongst the symptoms through which 
HPS manifests itself, the most frequent one is effort 
dyspnoea, occurring in 80% of cases. Much less 
frequent symptoms are chest pain and fainting [19]. 
From the group of signs, lesions characteristic for 
liver diseases, such as spider angioma or palmar 
erythema, or changes connected with the portal hy-
pertension, such as e.g. ascites and splenomegalia, 
can be observed. Over time physical manifestations 
of the blood oxygenation defect appear, such as 
digital clubbing or central cyanosis [19, 20].
Summing up, the hepatopulmonary syn-
drome is a rare cause of oxygenation disorders. 
If there are no significant deviations in examina-
tions performed within the scheme of dyspnoea 
diagnostics, it is recommended to perform basic 
screening tests towards this syndrome (standing 
and supine saturation measurement, echocardi-
ography with the intake of shaken saline), even if 
there are no signs of the syndrome, or no history 
that would be suggestive of potential liver damage. 
Conflict of interest
The authors declare no conflict of interest.
References:
1. Dubrey S, Pal S, Singh S, et al. Digital clubbing: forms, asso-
ciations and pathophysiology. Br J Hosp Med (Lond). 2016; 
77(7): 403–408, doi: 10.12968/hmed.2016.77.7.403, indexed in 
Pubmed: 27388379.
2. Zulkifli A, Hilman Zulkifli A, Nadim Marchian T. Hepatopul-
monary syndrome: a brief review. Rom J Intern Med. 2016: 1–11.
3. Rodríguez-Roisin R, Krowka MJ, Hervé Ph, et al. ERS Task Force 
Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Com-
mittee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir 
J. 2004; 24(5): 861–880, doi: 10.1183/09031936.04.00010904, 
indexed in Pubmed: 15516683.
4. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and 
orthodeoxia in cirrhosis. Chest. 1977; 72(3): 305–309, indexed 
in Pubmed: 891282.
5. Tumgor G. Cirrhosis and hepatopulmonary syndrome. World J 
Gastroenterol. 2014; 20(10): 2586–2594, doi: 10.3748/wjg.v20.
i10.2586, indexed in Pubmed: 24627594.
6. Mokhtarifar A, Azimi H, Esmaeelzadeh A, et al. Frequency of 
Hepatopulmonary Syndrome (HPS) Among Patients With Liver 
Cirrhosis: A Letter to Editor. Hepat Mon. 2016; 16(2): e35990, 
doi: 10.5812/hepatmon.35990, indexed in Pubmed: 27148388.
7. Cosarderelioglu C, Cosar AM, Gurakar M, et al. Hepatopulmo-
nary Syndrome and Liver Transplantation: A  Recent Review 
of the Literature. J Clin Transl Hepatol. 2016; 4(1): 47–53, doi: 
10.14218/JCTH.2015.00044, indexed in Pubmed: 27047772.
8. Krowka MJ, Fallon MB, Kawut SM, et al. International Liver 
Transplant Society Practice Guidelines: Diagnosis and Mana-
gement of Hepatopulmonary Syndrome and Portopulmonary 
Hypertension. Transplantation. 2016; 100(7): 1440–1452, doi: 
10.1097/TP.0000000000001229, indexed in Pubmed: 27326810.
9. Stoller JK, Lange PA, Westveer MK, et al. Prevalence and reversi-
bility of the hepatopulmonary syndrome after liver transplanta-
tion. The Cleveland Clinic experience. West J Med. 1995; 163(2): 
133–138, indexed in Pubmed: 7571560.
10. Machicao VI, Balakrishnan M, Fallon MB. Pulmonary compli-
cations in chronic liver disease. Hepatology. 2014; 59(4): 1627–
1637, doi: 10.1002/hep.26745, indexed in Pubmed: 24089295.
11. Abrams GA, Jaffe CC, Hoffer PB, et al. Diagnostic utility of con-
trast echocardiography and lung perfusion scan in patients with 
hepatopulmonary syndrome. Gastroenterology. 1995; 109(4): 
1283–1288, indexed in Pubmed: 7557096.
12. Roberts DN, Arguedas MR, Fallon MB. Cost-effectiveness of 
screening for hepatopulmonary syndrome in liver transplant 
candidates. Liver Transpl. 2007; 13(2): 206–214, doi: 10.1002/
lt.20931, indexed in Pubmed: 17205561.
13. Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome-
-a  liver-induced lung vascular disorder. N Engl J Med. 2008; 
358(22): 2378–2387, doi: 10.1056/NEJMra0707185, indexed in 
Pubmed: 18509123.
14. Corley DA, Scharschmidt B, Bass N, et al. Lack of efficacy of 
TIPS for hepatopulmonary syndrome. Gastroenterology. 1997; 
113(2): 728–730, indexed in Pubmed: 9247498.
15. Paramesh AS, Husain SZ, Shneider B, et al. Improvement of 
hepatopulmonary syndrome after transjugular intrahepatic por-
tasystemic shunting: case report and review of literature. Pediatr 
Transplant. 2003; 7(2): 157–162, indexed in Pubmed: 12654059.
16. Tsauo J, Weng N, Ma H, et al. Role of Transjugular Intrahepatic 
Portosystemic Shunts in the Management of Hepatopulmonary 
Syndrome: A Systemic Literature Review. J Vasc Interv Radiol. 
2015; 26(9): 1266–1271, doi: 10.1016/j.jvir.2015.04.017, indexed 
in Pubmed: 26074026.
17. Fallon MB, Krowka MJ, Brown RS, et al. Pulmonary Vascular 
Complications of Liver Disease Study Group. Impact of hepa-
topulmonary syndrome on quality of life and survival in liver 
transplant candidates. Gastroenterology. 2008; 135(4): 1168–1175, 
doi: 10.1053/j.gastro.2008.06.038, indexed in Pubmed: 18644373.
18. Taillé C, Cadranel J, Bellocq A, et al. Liver transplantation for 
hepatopulmonary syndrome: a  ten-year experience in Paris, 
France. Transplantation. 2003; 75(15): 1482–1489.
19. Medarov BI, Chopra A, Judson MA. Clinical aspects of portopul-
monary hypertension. Respir Med. 2014; 108(7): 943–954, doi: 
10.1016/j.rmed.2014.04.004, indexed in Pubmed: 24816204.
20. Ramalingam VS, Ansari S, Fisher M. Respiratory Complication 
in Liver Disease. Crit Care Clin. 2016; 32(3): 357–369, doi: 
10.1016/j.ccc.2016.03.002, indexed in Pubmed: 27339676.
